Literature DB >> 29878934

Comedonecrosis Revisited: Strong Association With Intraductal Carcinoma of the Prostate.

Samson W Fine1, Hikmat A Al-Ahmadie, Ying-Bei Chen, Anuradha Gopalan, Satish K Tickoo, Victor E Reuter.   

Abstract

From the advent of the Gleason grading system for prostate cancer, cancer displaying intraluminal necrotic cells and/or karyorrhexis within cribriform/solid architecture, a phenomenon termed "comedonecrosis," has been assigned pattern 5. Intraductal carcinoma (IDC-P) shows morphologic overlap with high-grade cribriform/solid adenocarcinoma architecturally and cytologically and may also show central necrosis, yet due to the presence of basal cells at the duct periphery is not currently assigned a grade in clinical practice. On the basis of observations from routine clinical cases, we hypothesized that comedonecrosis was more significantly associated with IDC-P than invasive disease. From a large series of mapped radical prostatectomy specimens (n=933), we identified 125 high-grade (≥Gleason score 4+3=7), high-volume tumors with available slides for review. All slides were examined for the presence of unequivocal comedonecrosis. Standard immunohistochemistry for basal cell markers was performed to detect basal cell labeling in these foci. In total, 19 of 125 (15%) cases showed some ducts with comedonecrosis-9 cases with 1 focus and 10 cases with ≥2 foci; in all, a total of 73 foci of true comedonecrosis were evaluated. Immunohistochemical stains revealed labeling for basal cell markers in a basal cell distribution for at least some comedonecrosis foci in 18 of 19 (95%) cases, 12 with IDC-P exclusively and 6 with a mix of IDC-P and invasive carcinoma comedonecrosis foci. These results suggest that comedonecrosis is strongly associated with IDC-P and hence, the routine assignment of pattern 5 to carcinoma exhibiting comedonecrosis should be reconsidered.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29878934      PMCID: PMC6041141          DOI: 10.1097/PAS.0000000000001104

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  36 in total

1.  Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings.

Authors:  Brian D Robinson; Jonathan I Epstein
Journal:  J Urol       Date:  2010-08-17       Impact factor: 7.450

2.  Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective Cohort.

Authors:  Jesse K McKenney; Wei Wei; Sarah Hawley; Heidi Auman; Lisa F Newcomb; Hilary D Boyer; Ladan Fazli; Jeff Simko; Antonio Hurtado-Coll; Dean A Troyer; Maria S Tretiakova; Funda Vakar-Lopez; Peter R Carroll; Matthew R Cooperberg; Martin E Gleave; Raymond S Lance; Dan W Lin; Peter S Nelson; Ian M Thompson; Lawrence D True; Ziding Feng; James D Brooks
Journal:  Am J Surg Pathol       Date:  2016-11       Impact factor: 6.394

3.  Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.

Authors:  D F Gleason; G T Mellinger
Journal:  J Urol       Date:  1974-01       Impact factor: 7.450

Review 4.  Histologic grading of prostate cancer: a perspective.

Authors:  D F Gleason
Journal:  Hum Pathol       Date:  1992-03       Impact factor: 3.466

5.  Survival rates of patients with prostatic cancer, tumor stage, and differentiation--preliminary report.

Authors:  J C Bailar; G T Mellinger; D F Gleason
Journal:  Cancer Chemother Rep       Date:  1966-03

6.  ETS gene aberrations in atypical cribriform lesions of the prostate: Implications for the distinction between intraductal carcinoma of the prostate and cribriform high-grade prostatic intraepithelial neoplasia.

Authors:  Bo Han; Khalid Suleman; Lei Wang; Javed Siddiqui; Linda Sercia; Cristina Magi-Galluzzi; Nallasivam Palanisamy; Arul M Chinnaiyan; Ming Zhou; Rajal B Shah
Journal:  Am J Surg Pathol       Date:  2010-04       Impact factor: 6.394

Review 7.  A post-radical-prostatectomy nomogram incorporating new pathological variables and interaction terms for improved prognosis.

Authors:  Beverley A O'Brien; Ronald J Cohen; Thomas M Wheeler; Rachael E Moorin
Journal:  BJU Int       Date:  2010-08-12       Impact factor: 5.588

8.  Patterns of differentiation and proliferation in intraductal carcinoma of the prostate: significance for cancer progression.

Authors:  R J Cohen; J E McNeal; T Baillie
Journal:  Prostate       Date:  2000-04-01       Impact factor: 4.104

Review 9.  The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.

Authors:  Jonathan I Epstein; Lars Egevad; Mahul B Amin; Brett Delahunt; John R Srigley; Peter A Humphrey
Journal:  Am J Surg Pathol       Date:  2016-02       Impact factor: 6.394

10.  Cribriform carcinoma of the prostate and cribriform prostatic intraepithelial neoplasia: incidence and clinical implications.

Authors:  M A Rubin; A de La Taille; E Bagiella; C A Olsson; K M O'Toole
Journal:  Am J Surg Pathol       Date:  1998-07       Impact factor: 6.394

View more
  7 in total

1.  Aberrant Expression of p63 in an Adenocarcinoma of the Prostate That Has Metastasized to the Oral Cavity.

Authors:  Rafiq Khalid; Anand Ramanathan; Heng Tee Lun; Daniel Lim
Journal:  Cureus       Date:  2022-03-01

Review 2.  WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer.

Authors:  James G Kench; Mahul B Amin; Daniel M Berney; Eva M Compérat; Ian A Cree; Anthony J Gill; Arndt Hartmann; Santosh Menon; Holger Moch; George J Netto; Maria R Raspollini; Mark A Rubin; Puay Hoon Tan; Toyonori Tsuzuki; Samra Turjalic; Theo H van der Kwast; Ming Zhou; John R Srigley
Journal:  Histopathology       Date:  2022-08-02       Impact factor: 7.778

3.  The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma.

Authors:  Geert J L H van Leenders; Theodorus H van der Kwast; David J Grignon; Andrew J Evans; Glen Kristiansen; Charlotte F Kweldam; Geert Litjens; Jesse K McKenney; Jonathan Melamed; Nicholas Mottet; Gladell P Paner; Hemamali Samaratunga; Ivo G Schoots; Jeffry P Simko; Toyonori Tsuzuki; Murali Varma; Anne Y Warren; Thomas M Wheeler; Sean R Williamson; Kenneth A Iczkowski
Journal:  Am J Surg Pathol       Date:  2020-08       Impact factor: 6.298

4.  Intraductal carcinoma has a minimal impact on Grade Group assignment in prostate cancer biopsy and radical prostatectomy specimens.

Authors:  L Lucia Rijstenberg; Tim Hansum; Eva Hollemans; Charlotte F Kweldam; Intan P Kümmerlin; Chris H Bangma; Theodorus H van der Kwast; Monique J Roobol; Geert J L H van Leenders
Journal:  Histopathology       Date:  2020-09-11       Impact factor: 5.087

Review 5.  Intraductal carcinoma of the prostate.

Authors:  Eszter Szentirmai; Giovanna Angela Giannico
Journal:  Pathologica       Date:  2020-03

6.  Identification of Morphologic Criteria Associated with Biochemical Recurrence in Intraductal Carcinoma of the Prostate.

Authors:  Mame-Kany Diop; Roula Albadine; André Kougioumoutzakis; Nathalie Delvoye; Hélène Hovington; Alain Bergeron; Yves Fradet; Fred Saad; Dominique Trudel
Journal:  Cancers (Basel)       Date:  2021-12-13       Impact factor: 6.639

7.  Comedonecrosis Gleason pattern 5 is associated with worse clinical outcome in operated prostate cancer patients.

Authors:  Tim Hansum; Eva Hollemans; Esther I Verhoef; Chris H Bangma; John Rietbergen; Susanne Osanto; Rob C M Pelger; Tom van Wezel; Henk van der Poel; Elise Bekers; Jozien Helleman; Sebastiaan Remmers; Geert J L H van Leenders
Journal:  Mod Pathol       Date:  2021-06-26       Impact factor: 7.842

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.